<?xml version='1.0' encoding='utf-8'?>
<document id="28374976"><sentence text="Peroxisome Proliferator-Activated Receptor α Activation Suppresses Cytochrome P450 Induction Potential in Mice Treated with Gemfibrozil."><entity charOffset="124-135" id="DDI-PubMed.28374976.s1.e0" text="Gemfibrozil" /></sentence><sentence text="Gemfibrozil, a peroxisome proliferator-activated receptor α (PPARα) agonist, is widely used for hypertriglyceridaemia and mixed hyperlipidaemia"><entity charOffset="0-11" id="DDI-PubMed.28374976.s2.e0" text="Gemfibrozil" /></sentence><sentence text=" Drug-drug interaction of gemfibrozil and other PPARα agonists has been reported"><entity charOffset="26-37" id="DDI-PubMed.28374976.s3.e0" text="gemfibrozil" /></sentence><sentence text=" However, the role of PPARα in cytochrome P450 (CYP) induction by fibrates is not well known" /><sentence text=" In this study, wild-type mice were first fed gemfibrozil-containing diets (0"><entity charOffset="46-57" id="DDI-PubMed.28374976.s5.e0" text="gemfibrozil" /></sentence><sentence text="375%, 0" /><sentence text="75% and 1" /><sentence text="5%) for 14 days to establish a dose-response relationship for CYP induction" /><sentence text=" Then, wild-type mice and Pparα-null mice were treated with a 0" /><sentence text="75% gemfibrozil-containing diet for 7 days"><entity charOffset="4-15" id="DDI-PubMed.28374976.s10.e0" text="gemfibrozil" /></sentence><sentence text=" CYP3a, CYP2b and CYP2c were induced in a dose-dependent manner by gemfibrozil"><entity charOffset="67-78" id="DDI-PubMed.28374976.s11.e0" text="gemfibrozil" /></sentence><sentence text=" In Pparα-null mice, their mRNA level, protein level and activity were induced more than those in wild-type mice" /><sentence text=" So, gemfibrozil induced CYP, and this action was inhibited by activated PPARα"><entity charOffset="5-16" id="DDI-PubMed.28374976.s13.e0" text="gemfibrozil" /></sentence><sentence text=" These data suggested that the induction potential of CYPs was suppressed by activated PPARα, showing a potential role of this receptor in drug-drug interactions and metabolic diseases treated with fibrates" /><sentence text="" /></document>